The company's purpose is to acquire, hold, manage and sell, as well as finance companies, in particular from the biotechnology sector. The company may establish branches in Switzerland and abroad, set up subsidiaries, participate in related companies, acquire, hold, manage, encumber, utilize and sell real estate and intellectual property rights, and provide financing to affiliated and other companies, grant security of any kind, or otherwise secure or guarantee obligations of these companies. The company may also engage in any commercial, financial and other activities that appear to promote the purpose of the company or are connected with it. The company may provide direct or indirect financing to its direct or indirect subsidiaries and third parties, including its direct or indirect shareholders and their (direct or indirect) subsidiaries, grant security of any kind, including by way of pledges, fiduciary transfers or assignments of the company's assets, or guarantees, enter into joint and several liability or suretyships, or otherwise secure or guarantee obligations of these other companies, whether for consideration or not. Furthermore, the company may operate a liquidity adjustment/concentration of net liquidity (cash pooling) with the aforementioned companies or join such a system, including periodic account balancing. This may also be done without consideration, on preferential terms, without interest, excluding the company's profit motive, and assuming cluster risks.